U.S. CDC recommends re-isolation if COVID recurs after taking Pfizer’s pillTherapeuticsPatients who experience recurrence of COVID-19 symptoms after completing treatment with Pfizer’s drug Paxlovid should isolate again for five days, the U.S. Centers for Disease Control and Prevention said in an advisory issued on Tuesday. Read more May 24, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/04/ReutersPaxlovid.webp 800 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-05-24 12:00:122022-05-24 12:41:39U.S. CDC recommends re-isolation if COVID recurs after taking Pfizer’s pill